SCHEMBL15760437

SCHEMBL15760437

CCc1nc2cnccn2c1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
MAPT P10636 4/20 0.35
PARP1 P09874 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
SYK P43405 1/20 0.34
BRAF P15056 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18357422 0.84 DAPK3 (0.41) GAAALDH1A1KDM4EHPGDCASP1
SCHEMBL15760438 0.83 MAPK1 (0.48) GAAALDH1A1KDM4EHPGDCASP1
SCHEMBL20181666 0.80 MAPT (0.43) GAAALDH1A1KDM4EHPGDCASP1
SCHEMBL1965016 0.80 KMT2A (0.44) GAAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL20181578 0.77 CYP19A1 (0.46) GAAALDH1A1KDM4EALOX15MAPT
SCHEMBL20181579 0.77 SLC22A12 (0.37) GAAALDH1A1HPGDHSD17B10MAPT
SCHEMBL12294560 0.77 MAPK1 (0.54) GAAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL19700339 0.76 CDK9 (0.43) GAAALDH1A1KDM4EHPGDCASP1
SCHEMBL14754848 0.76 BRAF (0.36) GAAALDH1A1KDM4EHPGDCASP1
SCHEMBL13838190 0.74 GAA (0.34) GAAALDH1A1KDM4EHPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029389-B2 Anti-inflammation compounds INSTITUT PASTEUR KOREA (KR) 2015-05-12 US disclosed
US-9029389-B2 Anti-inflammation compounds INSTITUT PASTEUR KOREA (KR) 2015-05-12 US disclosed
US-20140155387-A1 Anti-Inflammation Compounds QURIENT, CO. LTD. (KR) 2014-06-05 US disclosed
US-20140155387-A1 Anti-Inflammation Compounds QURIENT, CO. LTD. (KR) 2014-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155387-A1 Anti-Inflammation Compounds NR0B1, NR0B2, NR5A2 GAA 4806/4885ALDH1A1 3926/4885KDM4E 2886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.